Trump's Tariff Plan Risks Higher Drug Prices and Shortages in U.S. Pharmaceutical Market - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Economy

Trump's Tariff Plan Risks Higher Drug Prices and Shortages in U.S. Pharmaceutical Market

share-iconTuesday, December 31 comment-icon3 weeks ago 6 views
News sources:
thehillTHEHILL
Trump's Tariff Plan Risks Higher Drug Prices and Shortages in U.S. Pharmaceutical Market

Credited from: THEHILL

  • President-elect Trump's proposed tariffs on imports could significantly affect the cost and availability of pharmaceutical drugs in the U.S.
  • The plan includes 25 percent tariffs on imports from Mexico, Canada, and expanded tariffs on Chinese products, which may drive up prices.
  • Industry experts warn that these tariffs could lead to shortages in generic drugs, which make up the majority of prescriptions in the U.S.
  • Approximately 90 percent of generics are affected by potential import price increases, heightening concerns over supply chain stability.
  • Healthcare stakeholders express skepticism about the feasibility of for medical supplies, noting that logistics may complicate tariffs’ effectiveness.

For more details, visit the original article here.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture